Search results
Joe Grogan: Access to new Alzheimer’s treatments bogged down by Medicare policy
Chicago Tribune· 2 days agoAlzheimer’s is a progressive, fatal disease that boggled scientists for a century. Now, at last, we...
Two Is Better Than One in the Alzheimer’s Market
The Wall Street Journal via Yahoo Finance· 2 days agoSales of Alzheimer’s drug Leqembi have been slow to take off. - Hannah Yoon for The Washington Post/Getty Images If you have a potentially massive market...
‘Reversing’ Alzheimer’s: Here are exercises to make the brain more resilient
Fox News· 7 days agoCan Alzheimer’s disease be reversed? Dr. Heather Sandison, a renowned expert in Alzheimer’s disease...
Alzheimer’s Foundation of America encouraged by new drug closer to FDA approval
WBRC Fox 6 Birmingham· 7 days agoFederal health advisers are recommending a new Alzheimer’s drug from Eli Lilly that slows the...
A look at Alzheimer’s Disease and how to care for your loved one
KNOE Monroe LA· 6 days agoAccording to the Alzheimer’s Association, over 95,000 people in Louisiana are living with Alzheimer’s disease. < ...
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune (Revised)
Zacks via Yahoo Finance· 4 days agoImmune ACIU. Here are highlights from Wednesday’s Analyst Blog: Alzheimers in Focus as Panel...
Annovis Bio (NYSE: ANVS) Announces Results of Recent Alzheimer's Study
Digital Journal· 6 days agoPRESS RELEASE Published June 12, 2024 InvestorBrandNetwork Annovis Bio (NYSE: ANVS) , a late-stage, clinical-drug-platform company developing novel therapies for neurodegenerative ...
Alzheon secures $100m to advance Alzheimer’s disease treatment
Pharmaceutical Technology via Yahoo Finance· 6 days agoClinical-stage biopharmaceutical company Alzheon has secured $100m in a Series E funding round to...
FDA Advisory Committee finds efficiency of donanemab for Alzheimer's treatment - WNKY News 40...
WNKY· 6 days agoA drug is showing promising results for treating early Alzheimer’s disease, and the Alzheimer’s...
New Alzheimer’s treatment could bring hope to local families impacted by the disease
WPXI via Yahoo News· 6 days agoEli Lilly developed a drug called Donanemab. “This is potentially the third FDA-approved medication for the actual treatment of the underlying biology of Alzheimer’
